Nusano is a private company that intends to bring stability to the underserved market of radioisotopes. We have developed a high current ion source and linear accelerator that allows us to remove the current limitations of radioisotopes manufacturing for medical application and innovation. The facility will include full processing for cGMP radioisotope production.
Radioisotopes are extraordinarily valuable in the medical field, enabling diagnostic imaging and therapeutics to detect illnesses and fight early-stage cancers.
The high operating cost of existing production methods, combined with a declining number of production facilities, is causing a global bottleneck that requires a new approach.
"From research into fundamental [Actinium] chemistry to the most promising clinical trials, the development of Actinium radiopharmaceuticals is slowed by the small supply and resulting high cost that makes it inaccessible to many researchers.
Patented, Breakthrough particle beam technology is capable of generating heavy ions orders of magnitude greater than any existing comparable source.
To meet the declining supply of radioisotopes worldwide, the Nusano accelerator facility will produce key medical radioisotopes at scale.
The facility can produce several otherwise unavailable or affordable radioisotopes, enabling the development of personalized cancer therapies
Nusano's accelerator consumes less energy to produce the same amount of radioisotopes compared to our competitors
Our production method does not require the use of Uranium in its production process
The facility houses a linear accelerator that is 10% of the size of competing linear accelerators
Latest news from Nusano
Welcome to our new website! This page will be periodically updated with news and information about the company.
Salt Lake City — The Utah Governor’s Office of Economic Opportunity is pleased to announce that Nusano, Inc. will open an office in Utah, adding up to 92 new high-paying Utah jobs in the next 15 years.
“Nusano will be an awesome addition to Utah’s growing life science industry,” says Dan Hemmert, the Office of Economic Opportunity’s executive director. “This growth will support almost 100 high-paying jobs, and we look forward to all that Nusano will bring to the state.”
Brian McKernan, serial entrepreneur of several life science startups, joins Nusano as the new CEO. Howard Lewin, the current CEO, will take on the role of the COO.
Brian brings 30+ years of experience in various industries, including life sciences, diagnostics, radiopharm/nuclear medicine technology, cannabis science/medicine, and financial services.
Nusano Inc Inc., an early stage biomedical company based in Westwood, has raised $41 million from investors, according to an Oct. 24 securities filing. The developer of radioisotopes raised $41,464,543 during a seed round from 11 investors, according to a filing to the U.S. Securities and Exchange Commission.
Nusano is pioneered and driven by leaders in Nuclear Medicine, radioisotope production, and commercialization
chief executive officer
Seasoned Life sciences CEO, Entrepreneur
CHIEF OPERATIONS OFFICER
Cardiology/Nuclear Medicine, Entrepreneur
chief technology officer
Plasma Physics, UCLA
Lead Project Manager
Director of Target Development
Director of Chemistry
Director of Engineering
Director of Hardware
Senior Director, Finance & Administration
Director of Human Resources
Senior project manager
Lead Mechanical Engineer
Senior Controls Engineer
Lead Facilities Engineer
Regulatory Affairs & QA Manager
Targetry Design Engineer
Controls Electrical Engineer
Sr. Administrative Specialist
HR Admin Coordinator
Document Control Manager
Sustaining Controls Engineer
Linac Technical Specialist
Our development offices are currently located in Valencia CA. The first facility will be located in Salt Lake City, UT
28575 Livingston Ave, Valencia, CA 91355